Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our portfolios
United States
United Kingdom
France
Deutschland
Schweiz (DE)
Suisse (FR)
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
FTSE 100
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Economic calendar
Listed company
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profits warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Commentaries
Index Analysis
Stock Trading Strategies
Commodity Analysis
Forex Analysis
Stock Picks
All stock picks
Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Screeners
Market Screener Home
Fundamental Analyse
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Technical Analysis
Oversold stocks
Overbought stocks
Close to resistances
Close to supports
Accumulation phase
Most volatile stocks
Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocks
Growth stocks
Undervalued Stocks
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Tools
Market Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
Our Services
Premium Access
Discover our Services
4-Traders Homepage
>
Equities
>
Nasdaq
>
Ironwood Pharmaceuticals, Inc.
IRWD
IRONWOOD PHARMACEUTICALS, INC. (IRWD)
Add to my list
Mes dernières consult.
Most popular
Manage my lists
Report
Delayed -
04/20 10:00:00 pm
17.28
USD
-1.65%
04/17
IRONWOOD PHARMA
: to Host First Quarter 2018 Investor Update Call
BU
04/11
IRONWOOD PHARMA
: Denner seeking Ironwood board seat
AQ
04/09
IRONWOOD PHARMA
: Announces Director Nomination from Sarissa Capital
PU
Summary
Quotes
Charts
News
Analysis
Calendar
Company
Financials
Consensus
Revisions
News Summary
Most relevant
All news
official Publications
Sector news
Tweets
Most relevant news about IRONWOOD PHARMACEUTICALS,
04/17
IRONWOOD PHARMACEUTICALS
: to Host First Quarter 2018 Investor Update Call
BU
04/11
IRONWOOD PHARMACEUTICALS
: Denner seeking Ironwood board seat
AQ
04/09
IRONWOOD PHARMACEUTICALS
: Announces Director Nomination from Sarissa Capital
PU
03/09
IRONWOOD PHARMACEUTICALS
: to Present at Upcoming March Investor Conferences
AQ
03/05
IRONWOOD PHARMACEUTICALS
: to Present at Upcoming March Investor Conferences
BU
03/01
IRONWOOD PHARMACEUTICALS
: Chief scientific officer of Ironwood Pharmaceuticals ..
AQ
02/19
IRONWOOD PHARMACEUTICALS
: Provides Fourth Quarter and Full Year 2017 Investor U..
AQ
02/15
IRONWOOD PHARMACEUTICALS (NASDAQ
: IRWD) reported earnings of ($0.14) per share ..
AQ
02/15
IRONWOOD PHARMACEUTICALS,INC. (NASDA
: IRWD) Files An 8-K Results of Operations ..
AQ
02/15
IRONWOOD PHARMACEUTICALS
: beats Street 4Q forecasts
AQ
02/15
IRONWOOD PHARMACEUTICALS
: Provides Fourth Quarter and Full Year 2017 Investor U..
BU
02/05
IRONWOOD PHARMACEUTICALS
: to Host Fourth Quarter and Full-Year 2017 Investor Up..
AQ
02/01
IRONWOOD PHARMACEUTICALS
: to Host Fourth Quarter and Full-Year 2017 Investor Up..
BU
01/30
IRONWOOD PHARMACEUTICALS,INC. (NASDA
: IRWD) Files An 8-K Costs Associated with ..
AQ
01/17
Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS P..
AQ
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
04/17
IRONWOOD PHARMACEUTICALS
: to Host First Quarter 2018 Investor Update Call
BU
04/11
IRONWOOD PHARMACEUTICALS
: Denner seeking Ironwood board seat
AQ
04/09
IRONWOOD PHARMACEUTICALS, INC (65IB)
: 5/1/2018 to 4/30/2023
AQ
04/09
65-- IRONWOOD PHARMACEUTICALS, INC (
: 5/1/2018 to 4/30/2023
AQ
04/09
IRONWOOD PHARMACEUTICALS
: Announces Director Nomination from Sarissa Capital
PU
03/15
RHYTHM PHARMACEUTICALS
: 6th Annual Chief Medical Officer Summit Announces the S..
AQ
03/09
IRONWOOD PHARMACEUTICALS
: to Present at Upcoming March Investor Conferences
AQ
03/05
IRONWOOD PHARMACEUTICALS
: to Present at Upcoming March Investor Conferences
BU
03/01
IRONWOOD PHARMACEUTICALS
: Chief scientific officer of Ironwood Pharmaceuticals ..
AQ
02/22
IRONWOOD PHARMACEUTICALS
: Management's Discussion and Analysis of Financial Con..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
04/19
Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17
GE rides gene therapy wave with ready-made viral drug factories
RE
04/12
GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12
UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12
TAKEDA SOUNDS OUT BANKS FOR LOANS AS
: sources
RE
04/12
TAKEDA SOUNDS OUT BANKS FOR LOANS AS
: sources
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/09
Ironwood investor Sarissa Capital to nominate board member
03/15
Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Confer..
03/12
Ironwood Pharmaceuticals (IRWD) Presents At 38th Annual Cowen and Company Hea..
03/09
Key events next week - healthcare (continued #5)
03/09
Key events next week - healthcare (continued #2)
03/08
Synergy Pharmaceuticals' Cash Flow And Prescription Trends
Latest Tweets
04/20
Berenberg Bank Begins Coverage on Ironwood Pharmaceuticals $IRWD
04/20
BREAKING
: Toowoomba trainer Mark Currie has been suspended and charged with '..
04/19
RECAP 4/19 +Pos Comments
: $WTTR$ $CIB $IRWD $INVA $REPH $PBCT $NTEC $SYNT -Ne..
1
04/19
$IRWD - Berenberg Bank Initiates Coverage on Ironwood Pharmaceuticals #IRWD
04/19
$IRWD initiated at Buy at Berenberg. PT $25
More tweets
Qtime:96
Financials ($)
Sales 2018
378 M
EBIT 2018
-60,5 M
Net income 2018
-88,3 M
Debt 2018
283 M
Yield 2018
-
P/E ratio 2018
-
P/E ratio 2019
EV / Sales 2018
7,64x
EV / Sales 2019
6,19x
Capitalization
2 607 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends IRONWOOD PHARMACEUTICALS,
Short Term
Mid-Term
Long Term
Trends
Bullish
Bullish
Neutral
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Average target price
16,9 $
Spread / Average Target
-2,1%
Consensus details
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers
Name
Title
Peter M. Hecht
Chief Executive Officer & Director
Terrance G. McGuire
Chairman
William I. Huyett
Chief Operating Officer
Gina R. Consylman
CFO, CAO, Controller & VP-Finance
Mark G. Currie
Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.
Capitalization (M$)
IRONWOOD PHARMACEUTICALS, INC.
15.28%
2 607
CELLTRION, INC.
--.--%
31 467
IQVIA HOLDINGS INC
-0.64%
20 258
LONZA GROUP
-6.95%
18 703
INCYTE CORPORATION
-27.09%
14 493
NEKTAR THERAPEUTICS
44.36%
13 873
More Results
Copyright © 2018 Surperformance. All rights reserved.
Slave